We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.55B
AUM Growth
+$1.04B
Cap. Flow
+$118M
Cap. Flow %
1.81%
Top 10 Hldgs %
51.69%
Holding
171
New
48
Increased
43
Reduced
20
Closed
19

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$177M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$96.7M
4
INSP icon
Inspire Medical Systems
INSP
+$91.9M
5
COGT icon
Cogent Biosciences
COGT
+$76M

Top Sells

Rank Stock Value
1
OSCR icon
Oscar Health
OSCR
+$250M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$74.9M
3
BAX icon
Baxter International
BAX
+$47.7M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$42.6M
5
UTHR icon
United Therapeutics
UTHR
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 91.55%
2 Real Estate 0.38%
3 Financials 0.07%
4 Consumer Staples 0.07%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVUE icon
76
Kenvue
KVUE
$37.4B
$3.15M 0.05%
+193,853
New +$3.96M
ALEC icon
77
Alector
ALEC
$168M
$3.12M 0.05%
1,055,192
– –
ATRC icon
78
AtriCure
ATRC
$1.89B
$3.09M 0.05%
87,569
+76,431
+686% +$2.63M
BSX icon
79
Boston Scientific
BSX
$67.6B
$3.06M 0.05%
+31,312
New +$3.24M
TXG icon
80
10x Genomics
TXG
$5.83B
$3.05M 0.05%
261,188
+249,887
+2,211% +$3.26M
RDNT icon
81
RadNet
RDNT
$4.84B
$3.04M 0.05%
39,913
+38,407
+2,550% +$2.49M
IRTC icon
82
iRhythm Holdings
IRTC
$3.69B
$2.97M 0.05%
+17,262
New +$2.74M
COO icon
83
Cooper Companies
COO
$13.7B
$2.96M 0.05%
43,110
+36,782
+581% +$2.61M
RVTY icon
84
Revvity
RVTY
$12.1B
$2.94M 0.04%
+33,541
New +$3.05M
BLFS icon
85
BioLife Solutions
BLFS
$1.46B
$2.84M 0.04%
111,195
+97,525
+713% +$2.31M
LMAT icon
86
LeMaitre Vascular
LMAT
$2.26B
$2.62M 0.04%
29,959
+25,790
+619% +$2.3M
STAA icon
87
STAAR Surgical
STAA
$1.14B
$2.61M 0.04%
+96,989
New +$2.31M
TRUP icon
88
Trupanion
TRUP
$1.08B
$2.47M 0.04%
+57,045
New +$2.71M
DVA icon
89
DaVita
DVA
$15.2B
$2.47M 0.04%
18,567
+16,466
+784% +$2.26M
ISRG icon
90
Intuitive Surgical
ISRG
$128B
$2.43M 0.04%
+5,438
New +$2.61M
WAT icon
91
Waters Corp
WAT
$36.4B
$2.36M 0.04%
+7,885
New +$2.38M
CRVL icon
92
CorVel
CRVL
$3.08B
$2.34M 0.04%
30,216
+28,223
+1,416% +$2.52M
ENOV icon
93
Enovis
ENOV
$1.63B
$2.1M 0.03%
69,213
+58,946
+574% +$1.79M
CHE icon
94
Chemed
CHE
$6.76B
$2.09M 0.03%
+4,664
New +$2.11M
ALHC icon
95
Alignment Healthcare
ALHC
$3.86B
$1.8M 0.03%
102,942
-239,616
-70% -$3.55M
ANNX icon
96
Annexon
ANNX
$841M
$1.78M 0.03%
583,913
– –
NHC icon
97
National Healthcare
NHC
$3.53B
$1.77M 0.03%
14,584
+11,658
+398% +$1.26M
RGEN icon
98
Repligen
RGEN
$7.39B
$1.73M 0.03%
12,909
+11,281
+693% +$1.37M
TFX icon
99
Teleflex
TFX
$5.8B
$1.66M 0.03%
13,572
+11,767
+652% +$1.43M
GEHC icon
100
GE HealthCare
GEHC
$27.8B
$1.65M 0.03%
+21,924
New +$1.64M
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2025 Portfolio in Review

As of Q3 2025, Deerfield Management held 171 positions worth $6.55B, up 19% from $5.51B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q3 2025 filing shows 48 new, 43 increased, 20 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 2,337,771 shares worth $105M. The largest sale was Oscar Health, an estimated $250M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 89% a quarter earlier, followed by Real Estate and Financials.

  • Deerfield Management's largest Q3 2025 buy was Bristol-Myers Squibb: 2,337,771 shares worth $105M.
  • Deerfield Management added most to Centene in Q3 2025, an estimated $177M increase.
  • Deerfield Management's biggest Q3 2025 reduction was Indivior Pharmaceuticals, cutting an estimated $74.9M.
  • Deerfield Management fully exited Oscar Health in Q3 2025, selling an estimated $250M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.55B portfolio in Q3 2025.
  • Deerfield Management opened 48 new positions and closed 19 in Q3 2025.
  • Deerfield Management's portfolio value rose 19% quarter-over-quarter to $6.55B.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.